Dark spots, four ingredients and one winner: how melanin inhibitors actually compare

Why dark spots resist most skincare approaches

A dark spot — whether from sun exposure, post-inflammatory hyperpigmentation after a breakout, or hormonal changes — is a localised excess of melanin produced by melanocyte cells in the skin's basal layer. The melanin itself is not visible at the surface immediately: it travels upward as skin cells renew, appearing as a dark patch when the pigment-loaded cells reach the epidermis. This means that even an effective brightening treatment applied at the surface must either interrupt the melanin production cycle at the source, accelerate the removal of already-pigmented cells at the surface, or do both simultaneously. Treatments that only moisturise or exfoliate the surface shift the problem temporarily but do not alter the melanocyte behaviour driving it.

How tranexamic acid and cysteine target melanin production

Tranexamic acid works by interfering with the UV-induced stimulation pathway that instructs melanocytes to produce more melanin — specifically, it blocks the interaction between keratinocytes and melanocytes that occurs after UV exposure. It is particularly effective for post-sun spots and melasma, which have a strong UV-trigger component, and it has an unusually good tolerability profile, remaining effective on sensitive skin that cannot use stronger actives. Cysteine (a sulfur-containing amino acid) targets melanin at an earlier point in the production chain: it competes for the enzyme tyrosinase, which is the rate-limiting step in melanin synthesis. The practical effect is that cysteine reduces the quantity of melanin produced per melanocyte, gradually lightening existing spots while preventing new ones from forming at the same rate.

Glutathione: the cellular antioxidant repurposed for brightening

Glutathione is the body's primary intracellular antioxidant — present in every cell, it manages oxidative stress and supports cellular detoxification processes. Its brightening action comes from a different pathway than most depigmenting ingredients: glutathione shifts melanin production from eumelanin (darker brown-black pigment) toward phaeomelanin (lighter yellow-red pigment), effectively changing the type of melanin skin produces rather than stopping production. The phospholipid capsule delivery format used in high-concentration glutathione ampoules is designed to overcome the molecule's poor skin penetration in its free form — encapsulating it in lipid structures that merge with the stratum corneum's own lipid matrix and release the active deeper in the epidermis where melanocytes are located.

Ascorbic acid as the speed variable in the brightening equation

Vitamin C (L-ascorbic acid) acts on tyrosinase, like cysteine, but also performs post-production reduction of already-formed dopaquinone back into DOPA — interrupting the melanin synthesis chain at two points rather than one. The challenge with ascorbic acid in brightening products is stability: it oxidises rapidly and loses efficacy when exposed to air or light, which is why its concentration in a product does not always correlate to its in-use effectiveness. Stabilised forms (ascorbyl glucoside, ascorbyl tetraisopalmitate) sacrifice some potency for shelf life. Creams combining ascorbic acid with tranexamic acid and cysteine are targeting melanin through multiple pathways simultaneously — the ascorbic acid handles tyrosinase and post-production reduction, cysteine reduces synthesis rate, and tranexamic acid blocks the UV stimulation signal upstream of all three.

Who benefits most from which brightening approach

Post-inflammatory hyperpigmentation from acne responds best to combined approaches: tranexamic acid and cysteine address the inflammation-triggered production, while an exfoliating active (AHA or gentle PHA) removes the already-formed pigment more quickly from the surface. Sun-induced spots require the UV-signal interruption that tranexamic acid provides, plus SPF to prevent reactivation. Melasma — the most treatment-resistant form of hyperpigmentation — requires the most consistent multi-ingredient approach and SPF every single day without exception; tranexamic acid is one of the only topical actives with documented efficacy specifically for melasma. Dull, grey-toned skin without specific spots benefits most from glutathione-type approaches that shift the baseline melanin type rather than targeting individual lesions.